Aj. Mundt et al., Initial clinical experience with intensity-modulated whole-pelvis radiation therapy in women with gynecologic malignancies, GYNECOL ONC, 82(3), 2001, pp. 456-463
Objective. Our goal in this article to describe our initial experience with
intensity-modulated whole-pelvis radiation therapy (IM-WPRT) in gynecologi
c malignancies.
Methods. Between February and August 2000, 15 women with cervical (9) or en
dometrial (6) cancer received IM-WPRT. All patients received a treatment pl
anning computed tomography (CT) scan. On each scan, the target volume (uppe
r vagina, parametrial tissues, presacral region, uterus, and regional lymph
nodes) and normal tissues (small bowel, bladder, and rectum) were identifi
ed. Using commercially available software, an IM-WPRT plan was generated fo
r each patient. The goal was to provide coverage of the target with the pre
scription dose (45 Gy) while minimizing the volume of small bowel, bladder,
and rectum irradiated. Acute gastrointestinal (GI) and genitourinary (GU)
toxic effects in these women were compared with those seen in 25 patients t
reated with conventional WPRT.
Results. IM-WPRT plans provided excellent coverage of the target structures
in all patients and were highly conformal, providing considerable sparing
of the bladder, rectum, and small bowel. Treatment was well tolerated, with
grade 0-1 GI and GU toxicity in 46 and 93% of patients, respectively. IM-W
PRT patients had a lower rate of grade 2 GI toxicity (53.4% vs 96%, P = 0.0
01) than those treated with conventional WPRT. Moreover, the percentage of
women requiring no or only infrequent antidiarrheal medications was lower i
n the IM-WPRT group (73.3% vs 20%, P = 0.001). While grade 2 GU toxicity wa
s also lower in the IM-WPRT patients (6.7% vs 16%), this difference did not
reach statistical significance (P = 0.38).
Conclusion. IM-WPRT provides excellent coverage of the target structures wh
ile sparing critical neighboring structures in gynecology patients. Treatme
nt is well tolerated with less acute GI toxicity than conventional WPRT. Mo
re patients and longer follow-up are needed to evaluate the full merits of
this approach. (C) 2001 Academic Press.